Immunometabolism and Metabolomics in Lung Disease

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".

Deadline for manuscript submissions: 20 February 2025 | Viewed by 81

Special Issue Editors


E-Mail
Guest Editor
Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy
Interests: pulmonary rare diseases; IPF; ILD; alpha 1-antitrypsin deficiency; COPD; lung physiopathology; metabolomics in lung pathology

E-Mail Website
Guest Editor
Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy
Interests: COPD; lung physiopathology; pulmonary rare diseases; IPF; ILD; alpha 1-antitrypsin deficiency; metabolomics in lung pathology

Special Issue Information

Dear Colleagues,

Metabolomics is the science that investigates the metabolites present in biologic samples, thus inferring with the metabolic and biologic pathways behind their production. More specifically, Metabolomics refers to the systematic analysis of analytes (the so-called metabolites) in a biologic matrix, attempting to identify biomarkers of disease or metabolic processes. In recent years, Metabolomics has started to be recognized as a useful scientific tool to unravel disease mechanisms and to integrate what genetics already can explain about lung diseases. In the future, Metabolomics is expected to clarify several mechanisms in both obstructive and restrictive lung diseases, such as Chronic Obstructive Lung Disease (COPD) and Interstitial Lung Disease (ILD), together with Pulmonary Vascular Disease and Lung Cancer. Moreover, the pathways of immunometabolism behind lung diseases are a topic that Metabolomics can successfully help in clarifying. Today, the determination of metabolomic profiles relies on different analytical methods and technologies, i.e., Mass Spectrometry (MS) and Nuclear Magnetic Resonance Spectroscopy (NMRS). Among the most used biomatrices for Metabolomics analysis are exhaled breath condensate (EBC) and plasma and bronchoalveolar lavage fluid (BALF).

The aim of this Special Issue is to collect clinical research and basic science studies to comprehensively explore the topic of Metabolomics and immunometabolism in lung diseases. Original articles and reviews are welcome. 

Dr. Claudio Tirelli
Prof. Dr. Stefano Centanni
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • metabolomics
  • lung physiopathology
  • biomarkers
  • COPD
  • ILD
  • nuclear magnetic resonance spectroscopy
  • mass spectrometry
  • exhaled breath condensate
  • metabolites
  • immunometabolism

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop